Latest 8-K filings

Nurix Therapeutics announced robust third-quarter 2026 financial results, highlighted by substantial revenue growth, advancement of its bexobrutinib program into Phase 3, and a strong cash position extending runway into late 2029.

FB Financial Corporation announced robust third-quarter 2026 financial results, showcasing significant loan and deposit growth, alongside solid profitability.

Tutor Perini Corporation announced the resignation of board designee Sidney Feltenstein, effective October 30, 2026, following a reduction in beneficial ownership below the threshold required by a shareholders agreement.

Braemar Hotels & Resorts Inc. has released preliminary unaudited financial results for the trailing twelve months ended August 31, 2026, highlighting key property-level performance metrics.

Hyperscale Data, Inc. has amended its At-the-Market (ATM) Issuance Sales Agreement, reducing the maximum offering amount by $200 million, citing current capital plans and a focus on disciplined management.

UnitedHealth Group reported robust third quarter 2026 results, with revenues of $112.7 billion and earnings from operations of $6.6 billion, leading to an updated and positive full-year earnings outlook.

Unity Bancorp announced robust third-quarter financial results, driven by significant loan and deposit growth, an expanded net interest margin, and improved asset quality.

Enovix Corporation announced preliminary Q326 revenue of $11.0 million, a 38% year-over-year increase that surpassed guidance, driven by strong demand in the drone and defense sectors.

Co-Diagnostics, Inc. has entered into a senior secured convertible loan agreement with J.J. Astor & Co. for up to $3.1 million, with an initial funding of $2.1 million.

TTM Technologies announces a $400 million investment to expand manufacturing capacity in China and Malaysia, specifically targeting the growing demand for AI infrastructure.

Bausch + Lomb Corporation announced the mutual departure of CEO Brent Saunders, appointing Thomas J. Appio as interim CEO, while also signaling an expected raise in full-year 2026 adjusted EBITDA guidance.

SSR Mining announces an updated Technical Report Summary for its Marigold Complex, revealing a 43% increase in gold reserves to 4.6 million ounces and a 20-year life of mine plan with a $3.3 billion after-tax NPV.

Domino's Pizza announced robust third quarter 2026 financial results, showcasing global retail sales growth, increased income from operations, and significant net store growth.

SS Innovations International, Inc. has entered into a Securities Purchase Agreement to issue a secured convertible promissory note for $20 million to Growth Capital Partners, LLC.

Sino Green Land Corporation has converted over $2.4 million in unsecured loans into company stock, strengthening its balance sheet.

Humana Inc. announces a new joint venture with BlackRock to manage its CenterWell Senior Primary Care clinics, aiming for enhanced balance sheet efficiency and growth capital.

High Roller Technologies, Inc. issued a Form 8-K to correct an erroneous email regarding the launch date of its prediction markets product.

IX Acquisition Corp. announced the adjournment of its general meeting and shareholder approval for the Fifth Extension Amendment Proposal and Auditor Ratification Proposal, alongside 435,000 shares tendered for redemption.

IonQ, Inc. announced its definitive agreement to acquire Elisity, Inc. for up to $1.3 billion in an all-stock transaction to enhance its quantum security offerings.

ArriVent BioPharma has dosed the first patient in its U.S. Phase 1 trial for ARR-002, a novel dual-target antibody-drug conjugate for ovarian and endometrial cancer.

Charter Communications, Inc. announced the departure of its Executive Vice President, Chief Commercial Officer, Adam Ray, effective October 12, 2026.

Drilling Tools International Corporation announces plans for a U.S. dollar denominated senior secured bond issue to finance an acquisition, repay debt, and for general corporate purposes.

ImmuCell Corporation announced preliminary, unaudited sales results for Q3 2026, showing a significant 46% increase year-over-year.

ClearOne, Inc. has received a determination from Nasdaq to delist its securities due to non-compliance with the minimum stockholders equity requirement, with the company planning to appeal the decision.

BridgeBio Pharma announces FDA acceptance and Priority Review for its oral infigratinib NDA for children with achondroplasia, with a target action date of February 4, 2027.

Zenas BioPharma announced new data from its Phase 3 INDIGO trial of obexelimab for IgG4-related disease, showing sustained clinical activity, reduced glucocorticoid toxicity, and positive vaccine response findings.

EON Resources Inc. announced it can no longer rely on its previously issued 2025 financial statements due to an error in calculating depletion, depreciation, and amortization expense.

Autozone, Inc. announced that director Claire R. McDonough will not stand for re-election at the upcoming 2026 Annual Meeting of Stockholders due to a new executive role with conflicting commitments.

Gentherm Incorporated has filed an amendment to its Form 8-K to include unaudited pro forma condensed combined financial information following the completion of its transaction with Modine Manufacturing Company's Performance Technologies business.

Wheels Up Experience Inc. has filed an amendment to a previous 8-K report to correct inadvertent errors in the historical reconciliations of Adjusted EBITDA and Adjusted EBITDAR.